[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=77ac6501394779a348533b8d96a13cf15f47705111d2fb3b966d5847569b0650",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731429660,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 131416662,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=77ac6501394779a348533b8d96a13cf15f47705111d2fb3b966d5847569b0650"
    }
  },
  {
    "ts": null,
    "headline": "National Vision Q3 Earnings Top Estimates, Revenues Lag, Stock Tumbles",
    "summary": "EYE's third-quarter 2024 results reflect ongoing strength in Managed Care, with growth in America's Best stores.",
    "url": "https://finnhub.io/api/news?id=480bffd3d6643564406a32770d82070873e7cb418bcca67efabf88b1bc3dd155",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731413760,
      "headline": "National Vision Q3 Earnings Top Estimates, Revenues Lag, Stock Tumbles",
      "id": 131304486,
      "image": "https://media.zenfs.com/en/zacks.com/0ebf144352a95b22dfed01b36b0e82c5",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "EYE's third-quarter 2024 results reflect ongoing strength in Managed Care, with growth in America's Best stores.",
      "url": "https://finnhub.io/api/news?id=480bffd3d6643564406a32770d82070873e7cb418bcca67efabf88b1bc3dd155"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific resumes PFA trial in new patient group after pausing enrollment",
    "summary": "Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to anti-arrhythmic drugs in patients with persistent AFib, a spokesperson said.",
    "url": "https://finnhub.io/api/news?id=1847872d24c48dea0e8f9e82625355192bf5a8e90c51bd3cca666b516e31b95c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731409898,
      "headline": "Boston Scientific resumes PFA trial in new patient group after pausing enrollment",
      "id": 131327741,
      "image": "https://imgproxy.divecdn.com/C6WEtxKAs3oSjRPo1l23trIINQLtU7AvJllELh8ELYk/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlLzMxbW1fRmxvd2VyX0N1cnZlXy1fTm9fR3VpZGV3aXJlXy1fR2hvc3RfMS5wbmc=.webp",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to anti-arrhythmic drugs in patients with persistent AFib, a spokesperson said.",
      "url": "https://finnhub.io/api/news?id=1847872d24c48dea0e8f9e82625355192bf5a8e90c51bd3cca666b516e31b95c"
    }
  }
]